Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Current pricing is $75.00, and the product is intended for laboratory research use only
The lowest dose of 2.5 mg tirzepatide was the initiation dose for all patients and the dosages were up titrated and adjusted by the physicians based on individual patients glycemic and/or weight loss goal and adverse events of the treatment
Both substances can cause gastrointestinal symptoms including nausea, vomiting, and diarrhoea, which might potentially intensify when combined
Phase II trials showed promise for wound healing, but the company couldn't secure funding to continue through Phase III
US$ 21.46
US$ 23.26
US$ 24.74
US$ 23.48
